Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease
about
Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st centuryPeptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approachesModulation of the tumor microenvironment for cancer treatment: a biomaterials approachCurcumin nanoparticles ameliorate ICAM-1 expression in TNF-α-treated lung epithelial cells through p47 (phox) and MAPKs/AP-1 pathwaysDesign and optimization of PLGA-based diclofenac loaded nanoparticlesNanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 micePassively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In VivoNovel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.Curcumin: An age-old anti-inflammatory and anti-neoplastic agent.Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives.Critical evaluation of biodegradable polymers used in nanodrugs.Polymeric nanoparticles for targeted radiosensitization of prostate cancer cellsPreparation, characterisation and evaluation of curcumin with piperine-loaded cubosome nanoparticles.Evolution of availability of curcumin inside poly-lactic-co-glycolic acid nanoparticles: impact on antioxidant and antinitrosant properties.pH-Responsive PLGA Nanoparticle for Controlled Payload Delivery of Diclofenac Sodium.Nose-To-Brain Delivery of PLGA-Diazepam NanoparticlesCurcumin nanomedicine: a road to cancer therapeuticsNano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response.Natural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect.New treatment strategies for Alzheimer's disease: is there a hope?Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.Curcumin and neurodegenerative diseases: a perspective.Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin.Nanomaterials for reducing amyloid cytotoxicity.Targeted delivery of nano-therapeutics for major disorders of the central nervous system.Nanocarrier: a potential tool for future antioxidant therapy.Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders.Nanotherapeutic strategies for the treatment of Alzheimer's disease.Nanomedicine for the treatment of Alzheimer's disease.Nanotechnology based theranostic approaches in Alzheimer's disease management: Current status and future perspective.Docosahexaenoic acid-mediated, targeted and sustained brain delivery of curcumin microemulsion.A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies.Dual agents loaded polymeric nanoparticle: Effect of process variablesInhibition of β-amyloid peptide self-assembly and cytotoxicity by poly(LVFF-co-β-amino ester).Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.Development of a dual nanocarrier system as a potential stratagem against amyloid-induced toxicity.Nanobiomaterials' applications in neurodegenerative diseases.Single step synthesis, characterization and applications of curcumin functionalized iron oxide magnetic nanoparticles.Polysorbate-80-coated, polymeric curcumin nanoparticles for in vivo anti-depressant activity across BBB and envisaged biomolecular mechanism of action through a proposed pharmacophore model.
P2860
Q24630927-81FB2FF4-B82C-4C33-841E-20B704569ACDQ26795570-FE4E4ADF-DBA2-4B40-A493-A0E5C4A04E78Q26996790-DB2F2EBE-5EF6-4096-BFE5-3EF3EB5B6F58Q28487910-8A9D9041-BA79-4399-874E-F069605F4285Q28539253-3A033E7E-EB5B-4DFF-800D-104499EF8571Q30387307-74C46E00-94AD-47B8-8DAF-74422D773024Q30540417-7C633775-503A-46DF-828A-D7438DA0C021Q30978432-698FDE8B-A914-49B6-99B8-F23BE2E2CB25Q33624697-14202418-359B-4B61-BE7B-C93E22C6486FQ33896515-EC64416A-E313-4A51-9D36-76F45A1A5AB7Q34157584-8FCB3F1E-72E6-4BA8-A885-AB75D7E80602Q34976931-A37F65A9-7F2C-44EA-9B08-AF5777A31AE5Q35040431-7B455381-ED20-4769-B3DD-BFA5C98D290DQ35123608-A46BF31C-1FED-4452-9940-8DFB65A24542Q36010332-9DCA45F8-20D2-4623-AD3C-0C37932E8B51Q36094986-435122B0-83FE-4E64-9DDC-132358C86030Q36360517-027FC40F-8729-4416-A4CF-D227CD93B869Q36807261-5B922B8F-AD88-4DBF-B0FB-0B127C130AA6Q36881910-353A8C84-1933-4B03-9FCE-0591588BEC1AQ37098664-926902DA-9D7E-4F62-8782-DFAB6AEE78F8Q37403383-EC8F2F43-36B8-4BDE-A596-A8CC572578B5Q37607750-6928E44B-BD8A-4E0F-A47A-593DA77A8779Q38016212-4864F0D0-E714-4D08-9340-679DF2065C2EQ38042744-CAE44F5B-C790-42A8-9D79-653DF740AF38Q38110699-C334D949-D75B-40FF-B8A3-D5279868876CQ38116765-58C94930-38B2-44EA-AE6A-C1EF99F4CDC8Q38213492-C560CE57-E2BC-4B35-958F-2A02BD355A3DQ38229311-6716DEB1-C808-40EE-89C8-9F9C9C311409Q38358865-05BE1932-E21D-436B-8A9D-A1D3C69F4172Q38451932-DA79DEA6-0FCE-44DD-A778-5C1AF073DD07Q38686370-ECDFF214-937B-4D23-8456-9C953068147CQ38718141-3BEEC126-69B9-4916-9FFF-E73711C3DB38Q38758760-80C47D5E-E80D-414F-96C1-9EEC300E2DACQ38844946-0BFC2AB1-83B6-4D2B-9EB2-39023BEB6DF5Q38880298-C0827253-A809-4ACF-BD03-50D5046E0F44Q38884364-E8CDA935-7D35-43D0-BE2C-92E6A592CA89Q38996889-B418485E-2E4E-4A7F-8A8C-7514E4334108Q39126802-1B3A3554-64D4-4EC6-9CA1-6F9E4772609FQ41652740-0B0907A0-C8D9-4C20-A695-B4D03AC5F7C1Q42083769-2C339547-08B6-44CD-ABF8-E9B6B7C4DFD2
P2860
Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Curcumin loaded-PLGA nanoparti ...... ial use in Alzheimer's disease
@ast
Curcumin loaded-PLGA nanoparti ...... ial use in Alzheimer's disease
@en
Curcumin loaded-PLGA nanoparti ...... ial use in Alzheimer's disease
@nl
type
label
Curcumin loaded-PLGA nanoparti ...... ial use in Alzheimer's disease
@ast
Curcumin loaded-PLGA nanoparti ...... ial use in Alzheimer's disease
@en
Curcumin loaded-PLGA nanoparti ...... ial use in Alzheimer's disease
@nl
prefLabel
Curcumin loaded-PLGA nanoparti ...... ial use in Alzheimer's disease
@ast
Curcumin loaded-PLGA nanoparti ...... ial use in Alzheimer's disease
@en
Curcumin loaded-PLGA nanoparti ...... ial use in Alzheimer's disease
@nl
P2093
P2860
P921
P3181
P1433
P1476
Curcumin loaded-PLGA nanoparti ...... ial use in Alzheimer's disease
@en
P2093
Anila Mathew
D Sakthi Kumar
Hisao Morimoto
Kizhikkilot Venugopal
Takahiro Fukuda
Takashi Hasumura
Toru Maekawa
Yasuhiko Yoshida
Yutaka Nagaoka
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0032616
P407
P577
2012-01-01T00:00:00Z